Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -18.92% is 96% above its 5-year average of -515.01%, near the high end of its 5-year range (-11509.69%–18.39%).
2410.22% below its 12-month average of 0.82%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 18.39%.
OPERATING MARGIN
-18.92%
OPERATING MARGIN AVG TTM
0.82%
OPERATING MARGIN AVG 3Y
-99.32%
OPERATING MARGIN AVG 5Y
-515.01%
OPERATING MARGIN AVG 10Y
-2372.15%
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-2410.22%
CURRENT VS 3Y AVG
+80.95%
CURRENT VS 5Y AVG
+96.33%
CURRENT VS 10Y AVG
+99.20%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 288 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Ascendis Pharma A/S
Market Cap
$14.16B
Operating Margin
-18.92%
TTM Avg
0.82%
3Y Avg
-99.32%
5Y Avg
-515.01%
Market Cap
$14.64B
Operating Margin
-19.76%
TTM Avg
-59.77%
3Y Avg
-59.80%
5Y Avg
-72.77%
Market Cap
$14.79B
Operating Margin
39.88%
TTM Avg
32.73%
3Y Avg
24.94%
5Y Avg
21.46%
Market Cap
$14.97B
Operating Margin
12.35%
TTM Avg
9.13%
3Y Avg
12.39%
5Y Avg
13.51%
Market Cap
$13.19B
Operating Margin
0.77%
TTM Avg
13.08%
3Y Avg
19.11%
5Y Avg
24.45%
Market Cap
$15.24B
Operating Margin
24.99%
TTM Avg
19.38%
3Y Avg
20.05%
5Y Avg
20.47%
Market Cap
$12.95B
Operating Margin
-113.35%
TTM Avg
-190.29%
3Y Avg
-1892.24%
5Y Avg
-2358.01%
Market Cap
$12.89B
Operating Margin
10.15%
TTM Avg
12.77%
3Y Avg
11.89%
5Y Avg
11.41%
Market Cap
$12.52B
Operating Margin
-2.39%
TTM Avg
-1.31%
3Y Avg
-6.02%
5Y Avg
0.15%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Ascendis Pharma A/S (ASND) | $14.16B | -18.92% | 0.82% | -99.32% | -515.01% |
| Tempus AI, Inc. (TEM)vs › | $14.64B | -19.76% | -59.77% | -59.80% | -72.77% |
| Exelixis, Inc. (EXEL)vs › | $14.79B | 39.88% | 32.73% | 24.94% | 21.46% |
| Charles River Laboratories International, Inc. (CRL)vs › | $14.97B | 12.35% | 9.13% | 12.39% | 13.51% |
| Corcept Therapeutics Incorporated (CORT)vs › | $13.19B | 0.77% | 13.08% | 19.11% | 24.45% |
| Solventum Corporation (SOLV)vs › | $15.24B | 24.99% | 19.38% | 20.05% | 20.47% |
| BridgeBio Pharma, Inc. (BBIO)vs › | $12.95B | -113.35% | -190.29% | -1892.24% | -2358.01% |
| ICON Public Limited Company (ICLR)vs › | $12.89B | 10.15% | 12.77% | 11.89% | 11.41% |
| Baxter International Inc. (BAX)vs › | $12.52B | -2.39% | -1.31% | -6.02% | 0.15% |
| Penumbra, Inc. (PEN)vs › | $12.49B | 12.45% | 10.35% | 7.09% | 3.40% |
Gross Margin
90.2%
Operating Margin
-18.9%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 18.39% |
| 2026-03-31 | 10.06% |
| 2025-12-31 | 4.00% |
| 2025-09-30 | 5.15% |
| 2025-06-30 | -33.50% |
| 2025-03-31 | -103.23% |
| 2024-12-31 | 0.22% |
| 2024-09-30 | -167.28% |
| 2024-06-30 | -370.18% |
| 2024-03-31 | -51.25% |
| 2023-12-31 | -26.59% |
| 2023-09-30 | -279.82% |
| 2023-06-30 | -297.17% |
| 2023-03-31 | -427.77% |
| 2022-12-31 | -643.72% |
| 2022-09-30 | -945.09% |
| 2022-06-30 | -2303.46% |
| 2022-03-31 | -1875.06% |
| 2021-12-31 | -2298.98% |
| 2021-09-30 | -8709.07% |
| 2021-06-30 | -11509.69% |
| 2021-03-31 | -16709.12% |
| 2020-12-31 | -17877.20% |
| 2020-09-30 | -2859.09% |
| 2020-06-30 | -5776.25% |
| 2020-03-31 | -3290.11% |
| 2019-12-31 | -2586.68% |
| 2019-09-30 | -2408.16% |
| 2019-06-30 | -1606.20% |
| 2019-03-31 | -1039.55% |
| 2018-12-31 | -340.97% |
| 2018-09-30 | -191435.00% |
| 2018-06-30 | -252461.11% |
| 2018-03-31 | -125621.43% |
| 2017-12-31 | -11371.43% |
| 2017-09-30 | -7251.84% |
| 2017-06-30 | -5555.63% |
| 2017-03-31 | -6333.60% |
| 2016-12-31 | -2131.74% |
| 2016-09-30 | -1538.24% |
| 2016-06-30 | -1303.87% |
| 2016-03-31 | -1422.26% |
| 2015-12-31 | -708.55% |
| 2015-09-30 | -345.63% |
| 2015-06-30 | -660.94% |
| 2015-03-31 | -368.00% |
| 2014-12-31 | -249.86% |
| 2014-09-30 | -68.86% |
| 2014-06-30 | -55.71% |
| 2014-03-31 | -12.77% |
| 2013-12-31 | 41.03% |
| 2013-09-30 | 29.45% |
| 2013-06-30 | 13.79% |
| 2013-03-31 | 13.79% |
